<DOC>
	<DOCNO>NCT00213577</DOCNO>
	<brief_summary>The purpose study determine efficacy tolerance 2 dosage ( 750 versus 500 unit ) Dysport type A botulinic toxin patient suffer neurogenic urinary incontinence overactive bladder failure anticholinergic drug .</brief_summary>
	<brief_title>NEUROTOX : Two Dosages Type A Botulinic Toxin Neurogenic Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Neurogenic urinary incontinence urodynamic overactivity resistant anticholinergic Pregnancy Bladder cancer Symptomatic urinary infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>overactive neurogenic bladder</keyword>
</DOC>